IBD Self-management Website and Home Faecal Calprotectin Monitoring
NCT03671980 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11
Last updated 2018-09-14
Summary
6 month exploratory feasibility study to assess if a combination of MyMedicalRecord supported self-management website and a home faecal calprotectin smartphone testing kit is a feasible and acceptable means for patients to monitor for signs of relapse after treatment de-escalation.
Conditions
- Inflammatory Bowel Diseases
- Crohn Disease
- Ulcerative Colitis
- Self-care
Interventions
- OTHER
-
My Medical record website
Website comprising patient records, blood and other test results, useful information on IBD, and messaging service to communicate with IBD team, plus home smartphone faecal calprotectin monitoring.
Sponsors & Collaborators
-
University of Southampton
collaborator OTHER -
University Hospital Southampton NHS Foundation Trust
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-04-04
- Primary Completion
- 2018-04-30
- Completion
- 2018-06-30
Countries
- United Kingdom
Study Locations
More Related Trials
-
Evaluate Established Anti-DEFA5 mAbs Diagnostic Efficacy and Safety in IBD
NCT05663671 ·Status: UNKNOWN
-
TOD-IBD: Empowering Patients On-Demand
NCT06179563 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
A Study to Evaluate the Long-term Safety and Efficacy of Deucravacitinib in Participants With Crohn's Disease or Ulcerative Colitis
NCT04877990 ·Status: COMPLETED ·Phase: PHASE2
-
Fecal Biomarker Study for Patients With Ulcerative Colitis
NCT00780507 ·Status: COMPLETED
-
Real Life Remote Monitoring of Mild, Moderate and Severe Infectious Complications in IBD by Patient Reported Assessment
NCT04151420 ·Status: COMPLETED
-
Microbial and Human Determinants of the Onset of IBD Flares
NCT05463900 ·Status: ACTIVE_NOT_RECRUITING
-
Remote Monitoring of IBD
NCT05886322 ·Status: UNKNOWN
-
De-escalation of Anti-TNF Therapy in Inflammatory Bowel Disease
NCT04646187 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Stratifying Crohn's Using Biomarker Assessment
NCT04321863 ·Status: UNKNOWN
-
Genomic/Epigenomic Biomarkers of Deregulation of Immune System in Inflammatory Bowel Diseases
NCT02878395 ·Status: UNKNOWN
-
Cytokines and Genes in Therapeutic Response in Crohn's Disease
NCT03266471 ·Status: COMPLETED
-
Managing Infliximab Reinduction After Temporary Discontinuation of Drug
NCT02771457 ·Status: WITHDRAWN ·Phase: PHASE3
-
PET/CT to Predict Response to Infliximab Therapy in Patients With Crohn's Disease
NCT01759017 ·Status: TERMINATED
-
Does the Microbiome in IBD Change Alongside Special Treatment Scenarios?
NCT02526251 ·Status: COMPLETED
-
Evaluation of Therapeutic Strategy to Prevent Crohn's Disease Endoscopic poSToperatIve recurreNce Based on earlY Dosage of Faecal Calprotectin
NCT06972901 ·Status: RECRUITING ·Phase: NA
-
Improving Outcomes and Reducing Disparities for Patients With Inflammatory Bowel Disease Through Epidemiology and Enhanced Disease Management
NCT06424769 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Improving Outcomes Among Urgent Care Clinic Patients With Inflammatory Bowel Disease
NCT03239704 ·Status: UNKNOWN ·Phase: NA
-
The CalproSmartNOR Study - a New Clinical Tool for Monitoring Patients With Inflammatory Bowel Disease
NCT03486158 ·Status: COMPLETED ·Phase: NA
-
Web-based Monitoring in Children and Adolescents With Inflammatory Bowel Disease
NCT01860651 ·Status: COMPLETED ·Phase: NA
-
Endoscopic Relapse Risks Evaluation After Ileocolic Resection for Crohn's Disease
NCT06299631 ·Status: COMPLETED
-
Home basEd faecaL calProtectin Measurements Predicting Adalimumab Induction Destiny
NCT02634060 ·Status: COMPLETED ·Phase: NA
-
Stop Infliximab in Patients With Crohn's Disease
NCT00571337 ·Status: COMPLETED ·Phase: PHASE3
-
Research and Follow-up of the Determinants of the Progression and Complications of Inflammatory Bowel Diseases Treated or Not With Immunosuppressants.
NCT07172945 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Qualitative Study on Patients' (un)Ability and (un)Willingness to Use Telemonitoring in Inflammatory Bowel Diseases
NCT06123052 ·Status: COMPLETED
-
A Prospective Longitudinal Study of Fecal Microbiome and Calprotectin to Predict Relapse in Patients With IBD
NCT04079335 ·Status: UNKNOWN